» Articles » PMID: 16227984

A Function for Interleukin 2 in Foxp3-expressing Regulatory T Cells

Overview
Journal Nat Immunol
Date 2005 Oct 18
PMID 16227984
Citations 829
Authors
Affiliations
Soon will be listed here.
Abstract

Regulatory T cells (T(reg) cells) expressing the forkhead family transcription factor Foxp3 are critical mediators of dominant immune tolerance to self. Most T(reg) cells constitutively express the high-affinity interleukin 2 (IL-2) receptor alpha-chain (CD25); however, the precise function of IL-2 in T(reg) cell biology has remained controversial. To directly assess the effect of IL-2 signaling on T(reg) cell development and function, we analyzed mice containing the Foxp3(gfp) knock-in allele that were genetically deficient in either IL-2 (Il2(-/-)) or CD25 (Il2ra(-/-)). We found that IL-2 signaling was dispensable for the induction of Foxp3 expression in thymocytes from these mice, which indicated that IL-2 signaling does not have a nonredundant function in the development of T(reg) cells. Unexpectedly, Il2(-/-) and Il2ra(-/-) T(reg) cells were fully able to suppress T cell proliferation in vitro. In contrast, Foxp3 was not expressed in thymocytes or peripheral T cells from Il2rg(-/-) mice. Gene expression analysis showed that IL-2 signaling was required for maintenance of the expression of genes involved in the regulation of cell growth and metabolism. Thus, IL-2 signaling seems to be critically required for maintaining the homeostasis and competitive fitness of T(reg) cells in vivo.

Citing Articles

Aged regulatory T cells fail to control autoimmune lacrimal gland pathogenic CD4 T cells.

Scholand K, Schaefer L, Govindarajan G, Yu Z, Galletti J, de Paiva C Geroscience. 2025; .

PMID: 40053297 DOI: 10.1007/s11357-025-01576-y.


Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy.

Tanigawa K, Redmond W Oncoimmunology. 2025; 14(1):2452654.

PMID: 39812092 PMC: 11740684. DOI: 10.1080/2162402X.2025.2452654.


Interleukin-2 receptor signaling acts as a checkpoint that influences the distribution of regulatory T cell subsets.

Shouse A, Villarino A, Malek T iScience. 2025; 27(12):111248.

PMID: 39759017 PMC: 11700635. DOI: 10.1016/j.isci.2024.111248.


The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes.

Alvarez F, Acuff N, La Muraglia 2nd G, Sabri N, Milla M, Mooney J JCI Insight. 2024; 9(24).

PMID: 39704171 PMC: 11665582. DOI: 10.1172/jci.insight.182064.


CD137-expressing regulatory T cells in cancer and autoimmune diseases.

Lee K, Mei Y, Liu H, Schwarz H Mol Ther. 2024; 33(1):51-70.

PMID: 39668561 PMC: 11764688. DOI: 10.1016/j.ymthe.2024.12.010.